ERBB2 and breast cancer: Many principal factors, such as patient age, status of axillar lymph nodes, tumor size, histological traits, status of hormonal receptors and HER2, have been used for the prediction of the prognosis of BC patients for many years [24,25], but their roles in determining the individual risk level of the patient are quite limited.